Logo1
NASPGHAN - Pediatric Inflammatory Bowel Disease Evaluation and Management 2nd Edition - Slide Set
Mr pencil

How would you like your name to appear on your certificate?



Agreement
By completing this form, you attest that you have attended the activity in its entirety.
Post-Test Questions
Peak incidence of onset of IBD occur in childhood and adolescence between
Genetic influence appears to be lower in ulcerative colitis than in Crohn’s disease:
Patients with Crohn’s disease who are homozygous for NOD2/CARD15 mutations are at higher risk for manifesting what phenotype?
Laboratory tests may provide additional clues to the diagnosis. This may include:
Once an IBD diagnosis has been established, the clinician should evaluate for extra intestinal manifestations of the disease.
Impaired linear groth is more common in CD than in UC; this is most likely due to:
Corticosteroids are usually used as monotherapy in treating children with Crohn’s Disease.
There are no proven therapies to increase bone mass in children with IBD.
Which of the following agents primarily targets tumor necrosis factor alpha (TNF-α) to achieve a therapeutic response?
Which of the following is an absolute indication for recommending colectomy in ulcerative colitis?
Assessment of the nutritional status in a child with IBD should include:
Strategies for promoting adherence to medical therapies can include:
Please rate the following:
The program was relevant to my work.
Content matched stated objectives.
How well did the educational material give a balanced view of therapeutic options, including the use of generic names?
If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain:
Objective 1: Understand epidemiology of childhood IBD
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly learned strategies.
Objective 2: Describe the clinical manifestations and diagnostic assessment of Crohn’s disease and Ulcerative colitis in children
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly learned strategies.
Objective 3: Distinguish that childhood onset inflammatory bowel disease differs from adult onset disease
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly learned strategies.
Objective 4: Describe the extraintestinal manifestations and potential complications of inflammatory bowel disease in children
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly learned strategies.
Objective 5: Be familiar with appropriate use and potential adverse effects of therapeutic agents in IBD
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly learned strategies.
Please answer the following:
Do you believe this activity was appropriate for the scope of your professional practice?
Was the educational content scientifically sound?
Was the educational content free from commercial bias?
Was the mode of education effective for learning?

If there was off-label or investigational medications mentioned in this activity, was this information disclosed?

If you answered 'No' to any of the above questions, please explain:
What did you learn during this activity that you intend to integrate into your practice?
What questions have arisen in your practice for which you need answers/strategies that you can implement?
What patient problems or patient challenges do you feel you are not able to address appropriately or to your satisfaction?
What problems are your patients communicating to you that need attention or follow up?
Are you interested in basic, intermediate or advanced level trainings?
What barriers might you have that would interfere with implementation of new information from this training?
How could this training be improved to impact your competence or performance in practice?
Additional comments regarding this activity.
Please provide a fax number where you can be reached should the need arise.
Mr question